Annis Gardner Whiting Capital Advisors, LLC Moderna, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $236 Billion
- Q1 2025
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 7,529 shares of MRNA stock, worth $199,970. This represents 0.09% of its overall portfolio holdings.
Number of Shares
7,529
Previous 5,441
38.38%
Holding current value
$199,970
Previous $226 Million
5.65%
% of portfolio
0.09%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
873Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$679 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$663 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$472 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$198 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...